Flex Pharma
3 known investors
Flex Pharma provides accessible generic vasodilator medications, including PDE5 inhibitors, to U.S. patients at lower costs than brand-name alternatives. The company focuses on vessel health and blood flow optimization for applications ranging from athletic performance to sexual wellness.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
DR
Dr. Rod MacKinnonFounder
Investors · 3
In the news
- Flex Pharma dumps midstage trials, cuts workforce, mulls a sale to stay alive | Fierce Biotechfiercebiotech.com · 2018
- Boston’s Flex Pharma raises $86.4 million in IPO - The Boston Globebostonglobe.com · 2015
- Flex Pharma raises $86m in IPO -globalventuring.com · 2015
- Flex Pharma pulls off an $86M IPO for its cramp-treating spice cocktail | Fierce Biotechfiercebiotech.com · 2015
- Flex Pharma Raises $40M in Funding - FinSMEsfinsmes.com · 2014